The Tufts Center for the Study of Drug Development (CSDD) released a new report highlighting innovative approaches across the R&D continuum that pharmaceutical companies are implementing to drive efficiency and lower cost.
The Tufts Center for the Study of Drug Development (CSDD) released a new report highlighting innovative approaches across the R&D continuum that pharmaceutical companies are implementing to drive efficiency and lower cost. The new report, entitled "Profiles of New Approaches to Improving the Efficiency and Performance of Pharmaceutical Drug Development," details six primary areas across scientific, operating and manufacturing divisions including new approaches to validating drug targets; integrating real world data into the R&D process; flexible and adaptive clinical trials; and green manufacturing techniques driving efficiency while reducing carbon footprint.
